121 related articles for article (PubMed ID: 37201729)
21. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
[TBL] [Abstract][Full Text] [Related]
22. Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.
Matthes T; McKee T; Dunand-Sauthier I; Manfroi B; Park S; Passweg J; Huard B
Leukemia; 2015 Sep; 29(9):1901-8. PubMed ID: 25753925
[TBL] [Abstract][Full Text] [Related]
23. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.
Purushothaman A; Uyama T; Kobayashi F; Yamada S; Sugahara K; Rapraeger AC; Sanderson RD
Blood; 2010 Mar; 115(12):2449-57. PubMed ID: 20097882
[TBL] [Abstract][Full Text] [Related]
24. Genetic and enzymatic characterization of 3-O-sulfotransferase SNPs associated with Plasmodium falciparum parasitaemia.
Nguyen NT; Vivès RR; Torres M; Delauzun V; Saesen E; Roig-Zamboni V; Lortat-Jacob H; Rihet P; Bourne Y
Glycobiology; 2018 Jul; 28(7):534-541. PubMed ID: 29718295
[TBL] [Abstract][Full Text] [Related]
25. Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma.
Heidari-Hamedani G; Vivès RR; Seffouh A; Afratis NA; Oosterhof A; van Kuppevelt TH; Karamanos NK; Metintas M; Hjerpe A; Dobra K; Szatmári T
Cell Signal; 2015 Oct; 27(10):2054-67. PubMed ID: 26210886
[TBL] [Abstract][Full Text] [Related]
26. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation.
Dhodapkar MV; Abe E; Theus A; Lacy M; Langford JK; Barlogie B; Sanderson RD
Blood; 1998 Apr; 91(8):2679-88. PubMed ID: 9531576
[TBL] [Abstract][Full Text] [Related]
28. Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase.
Smeds E; Feta A; Kusche-Gullberg M
Glycobiology; 2010 Oct; 20(10):1274-82. PubMed ID: 20554947
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate structure in mice with genetically modified heparan sulfate production.
Ledin J; Staatz W; Li JP; Götte M; Selleck S; Kjellén L; Spillmann D
J Biol Chem; 2004 Oct; 279(41):42732-41. PubMed ID: 15292174
[TBL] [Abstract][Full Text] [Related]
30. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.
Bode L; Salvestrini C; Park PW; Li JP; Esko JD; Yamaguchi Y; Murch S; Freeze HH
J Clin Invest; 2008 Jan; 118(1):229-38. PubMed ID: 18064305
[TBL] [Abstract][Full Text] [Related]
31. Soluble syndecan-1 promotes growth of myeloma tumors in vivo.
Yang Y; Yaccoby S; Liu W; Langford JK; Pumphrey CY; Theus A; Epstein J; Sanderson RD
Blood; 2002 Jul; 100(2):610-7. PubMed ID: 12091355
[TBL] [Abstract][Full Text] [Related]
32. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
33. Heparan sulfate mediates trastuzumab effect in breast cancer cells.
Suarez ER; Paredes-Gamero EJ; Del Giglio A; Tersariol IL; Nader HB; Pinhal MA
BMC Cancer; 2013 Oct; 13():444. PubMed ID: 24083474
[TBL] [Abstract][Full Text] [Related]
34. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
Front Immunol; 2020; 11():1643. PubMed ID: 32849563
[No Abstract] [Full Text] [Related]
35. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
36. Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity.
Zhang Y; Wang N; Raab RW; McKown RL; Irwin JA; Kwon I; van Kuppevelt TH; Laurie GW
J Biol Chem; 2013 Apr; 288(17):12090-101. PubMed ID: 23504321
[TBL] [Abstract][Full Text] [Related]
37. Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.
Stanford KI; Wang L; Castagnola J; Song D; Bishop JR; Brown JR; Lawrence R; Bai X; Habuchi H; Tanaka M; Cardoso WV; Kimata K; Esko JD
J Biol Chem; 2010 Jan; 285(1):286-94. PubMed ID: 19889634
[TBL] [Abstract][Full Text] [Related]
38. Removal of syndecan-1 promotes TRAIL-induced apoptosis in myeloma cells.
Wu YH; Yang CY; Chien WL; Lin KI; Lai MZ
J Immunol; 2012 Mar; 188(6):2914-21. PubMed ID: 22308310
[TBL] [Abstract][Full Text] [Related]
39. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
40. Heparan sulfate 3-O-sulfation: a rare modification in search of a function.
Thacker BE; Xu D; Lawrence R; Esko JD
Matrix Biol; 2014 Apr; 35():60-72. PubMed ID: 24361527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
